Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures.

AIMS The number of implanted cardiac rhythm devices has rapidly increased in the past decade. Subsequently, the need for lead extraction has also increased. Several techniques of lead removal have been documented from manual traction of the lead to lead extraction assisted with mechanical or laser sheaths. The goal of this study was to review our experience with lead removal using manual traction without the assistance of extraction sheaths. METHODS AND RESULTS In the Leiden University Medical Center all leads are removed using manual traction without the assistance of extraction sheaths. We have retrospectively reviewed all lead removal procedures performed between 2000 and 2009. Procedures were reviewed for indication, success, complication rates, and mortality. In total, 279 lead removal procedures were included. During these procedures 445 leads were removed. Time since lead implantation: 4.2 ± 4.7 years. During extraction 53(11.9%) leads fractured, of which >50% could still be completely removed using a femoral approach. A longer implantation duration [odds ratio (OR) 1.16 per year, 95% confidence interval (CI) 1.09-1.23] and passive fixation (OR 2.52, 95%CI 1.17-5.45) significantly associated with the chance of lead fracture during lead removal. Clinical success, using the primary approach of manual traction from the pectoral area, was obtained in 228 (84.8%) procedures. Major complications occurred in 2(0.7%) and minor in 13(4.7%) procedures. One patient died within 24 h after the procedure due to septic shock. There was no further mortality within the first month after the procedure. CONCLUSION Lead removal using manual traction, without the assistance of lead extraction sheaths, is clinically successful in ~85% of the lead extraction procedures. Concomitant morbidity and mortality are low. The highest clinical success (~95%) was observed in patients with leads implanted less than 2.6 years.

[1]  Maria Grazia Bongiorni,et al.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). , 2009, Heart rhythm.

[2]  Vance G. Fowler,et al.  Staphylococcus aureus Bacteremia in Patients With Permanent Pacemakers or Implantable Cardioverter-Defibrillators , 2001, Circulation.

[3]  P. Neužil,et al.  Pacemaker and ICD lead extraction with electrosurgical dissection sheaths and standard transvenous extraction systems: results of a randomized trial. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  C. Kennergren,et al.  A single-centre experience of over one thousand lead extractions , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.

[6]  É. Marijon,et al.  Contributions of Advanced Techniques to the Success and Safety of Transvenous Leads Extraction , 2009, Pacing and clinical electrophysiology : PACE.

[7]  Z. Goldberger,et al.  Implantable cardioverter-defibrillators: expanding indications and technologies. , 2006, JAMA.

[8]  Samuel O Jones,et al.  Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. , 2008, Heart rhythm.

[9]  Macy C Smith,et al.  Extraction of Transvenous Pacing and ICD Leads , 2008, Pacing and clinical electrophysiology : PACE.

[10]  M. Onoe,et al.  Intravascular Extraction of Permanent Pacemaker Leads , 2002, Surgery Today.

[11]  D. Hayes,et al.  Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. , 2009, Heart rhythm.

[12]  Robert G. Hauser,et al.  Deaths and cardiovascular injuries due to device-assisted implantable cardioverter–defibrillator and pacemaker lead extraction , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  Luca Segreti,et al.  Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads , 2008, European heart journal.

[14]  T. D. Sellers,et al.  Clinical Study of the Laser Sheath for Lead Extraction: The Total Experience in the United States , 2002, Pacing and clinical electrophysiology : PACE.

[15]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[16]  Jeroen J. Bax,et al.  Implementation of Lead Safety Recommendations , 2010, Pacing and clinical electrophysiology : PACE.

[17]  D L Hayes,et al.  Pacemaker lead extraction with the laser sheath: results of the pacing lead extraction with the excimer sheath (PLEXES) trial. , 1999, Journal of the American College of Cardiology.

[18]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.

[19]  C. Ervin,et al.  Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. , 2010, Journal of the American College of Cardiology.

[20]  J. Morgan,et al.  Attitude towards redundant leads and the practice of lead extractions: a European survey. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.